COST-EFFECTIVENESS ANALYSIS OF USING KETOANALOGUES OF ESSENTIAL AMINOACIDS IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN KAZAKHSTAN

被引：0
|
作者：
Avdeyev, A. [1 ]
Gulyaev, A. [2 ]
Akhmedullin, R. [3 ]
机构：
[1] Med Ctr Hosp Presidents Affairs Adm Republ Kazakh, Nur Sultan, AKM, Kazakhstan
[2] Nazarbayev Univ, Astana, Kazakhstan
[3] Med Ctr Hosp Presidents Affairs Adm Republ Kazakh, Astana, AKM, Kazakhstan
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE115
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF TREATMENTS IN CHRONIC KIDNEY DISEASE IN MEXICO
    Frias Gasga, A. E.
    Cortes-Sanabria, L.
    Rueda Galicia, C.
    Soto, H.
    Guzman Vazquez, S.
    VALUE IN HEALTH, 2022, 25 (07) : S393 - S394
  • [2] Cost-Effectiveness Analysis of Screening Chronic Kidney Disease in Iran
    Ravaghi, Hamid
    Farzaneh, Ali
    Ebrahimnia, Mehdi
    Rostami, Zohreh
    Madani, Mohammad Hasan Hashemi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (11) : IC01 - IC04
  • [3] COST-EFFECTIVENESS ANALYSIS OF SUCROFERRIC OXYHYDROXIDE IN TREATMENT OF HYPERPHOSPHATEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Ugrekhelidze, D.
    Yagudina, R.
    Kulikov, A.
    VALUE IN HEALTH, 2016, 19 (07) : A518 - A518
  • [4] Screening for chronic kidney disease with microalbumin in hypertensive patients: A cost-effectiveness analysis.
    Berbano, E
    Abbott, K
    O'Malley, P
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 : 208 - 208
  • [5] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE IN THE NETHERLANDS
    Fens, T.
    Weersma, M.
    Postma, M. J.
    Boersma, C.
    de Jong, L.
    VALUE IN HEALTH, 2023, 26 (12) : S132 - S132
  • [6] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN THE TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE IN FRANCE
    Supiot, R.
    Tardu, J.
    Virely, N.
    Sivignon, M.
    Chollet, J.
    Uster, A.
    Levy, P.
    Massy, Z.
    VALUE IN HEALTH, 2024, 27 (12) : S365 - S365
  • [7] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS AFFECTED BY CHRONIC KIDNEY DISEASE IN ITALY
    Di Costanzo, A.
    Uster, A.
    Vassallo, C.
    Fiorentino, F.
    VALUE IN HEALTH, 2023, 26 (12) : S73 - S73
  • [8] Cost-effectiveness analysis of dapagliflozin for people with chronic kidney disease in Malaysia
    Lim, Soo Kun
    Lee, Shaun Wen Huey
    PLOS ONE, 2024, 19 (03):
  • [9] Use of surrogacy for women with chronic kidney disease: a cost-effectiveness analysis
    Farwell, Jennifer
    Wyatt, Solange
    Rueda, Jose
    Emerson, Jenna
    Page, Jessica
    Fowler, Jessica
    Allen, Allison
    Caughey, Aaron
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S153 - S153
  • [10] Progression of renal function in patients with chronic kidney disease on a low-protein diet supplemented with aminoacids and ketoanalogues
    Andrea Aimar, M.
    Pomiglio, Gabriela
    Baccaro, Fernando
    Traverso, Mario
    Audisio, Jorge
    De Feo, Priscila
    Crivelli, Adriana
    Flores Lazdin, Mariela
    NUTRICION HOSPITALARIA, 2018, 35 (03) : 655 - 660
12345